IL-3 is a novel target to interfere with tumor vasculature
Por um escritor misterioso
Descrição
Frontiers Molecules promoting circulating clusters of cancer cells suggest novel therapeutic targets for treatment of metastatic cancers
IL-3 is a novel target to interfere with tumor vasculature
Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications
Frontiers Tumor Endothelial Cells (TECs) as Potential Immune Directors of the Tumor Microenvironment – New Findings and Future Perspectives
Hallmarks of Cancer: The Next Generation: Cell
Antibody–drug conjugates: in search of partners of choice: Trends in Cancer
Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
New Technologies Bloom Together for Bettering Cancer Drug Conjugates
Senescent T cells: a potential biomarker and target for cancer therapy - eBioMedicine
Cancers, Free Full-Text
Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
IJMS, Free Full-Text
Cancers, Free Full-Text
de
por adulto (o preço varia de acordo com o tamanho do grupo)
